Stay updated with breaking news from Presenting Cells. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SQZ Biotechnologies (OTCMKTS:SQZB – Get Free Report) was the recipient of a significant decrease in short interest during the month of May. As of May 15th, there was short interest totalling 23,100 shares, a decrease of 27.8% from the April 30th total of 32,000 shares. Based on an average daily trading volume, of 30,400 shares, […]
Gamida Cell (NASDAQ:GMDA – Get Free Report) and SQZ Biotechnologies (NYSE:SQZ – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, institutional ownership, risk, valuation and dividends. Earnings and Valuation This table compares Gamida […]
SQZ Biotechnologies (NYSE:SQZ – Free Report) and Beam Therapeutics (NASDAQ:BEAM – Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends. Valuation & Earnings This table compares SQZ Biotechnologies and Beam […]
SQZ Biotechnologies (NYSE:SQZ – Free Report) shares are going to reverse split on Friday, July 7th. The 1-10 reverse split was announced on Friday, July 7th. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, July 7th. SQZ Biotechnologies Price Performance SQZ Biotechnologies stock opened at $0.44 on […]
SQZ Biotechnologies (NYSE:SQZ – Free Report) and Beam Therapeutics (NASDAQ:BEAM – Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, earnings, valuation and dividends. Analyst Ratings This is a summary of current ratings and […]